Alcresta Lands $49,389,680 New Financing Round

  • Feed Type
  • Date
  • Company Name
  • Mailing Address
    One Newton Executive Park Newton, MA 02462 USA
  • Company Description
    Alcresta’s enzyme expertise and proprietary platform enables novel products for those with compromised pancreatic output and malabsorption.
  • Website
  • Transaction Type
    Venture Equity
  • Transaction Amount
  • Transaction Round
  • Proceeds Purposes
    Total amount offered and sold include securities sold in connection with the conversion of convertible promissory notes. Proceeds purposes were not disclosed. 9 investors participated in the offering. The amount may include options, warrants or other securities. Contact technology company for investment details, if applicable. Not an offer or solicitation for the sale of securities or debt. SEC regulatory filing.
  • M&A Terms
  • Venture Investor

Trending on Xconomy